Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes

Background. At a university hospital in Korea, we conducted a retrospective study to determine the association of the progression of diabetic retinopathy (DR) with declining renal function in type 2 diabetes. Methods. We included a total of 1527 patients with type 2 diabetes who followed up in our d...

Full description

Saved in:
Bibliographic Details
Main Authors: AJin Cho, Hayne Cho Park, Young-Ki Lee, Young Joo Shin, So Hyun Bae, Hakyoung Kim
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/8784139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546960828006400
author AJin Cho
Hayne Cho Park
Young-Ki Lee
Young Joo Shin
So Hyun Bae
Hakyoung Kim
author_facet AJin Cho
Hayne Cho Park
Young-Ki Lee
Young Joo Shin
So Hyun Bae
Hakyoung Kim
author_sort AJin Cho
collection DOAJ
description Background. At a university hospital in Korea, we conducted a retrospective study to determine the association of the progression of diabetic retinopathy (DR) with declining renal function in type 2 diabetes. Methods. We included a total of 1527 patients with type 2 diabetes who followed up in our diabetes clinic and underwent fundus photographic examinations from August 2006 to February 2014. DR was assessed by retinal ophthalmologists using comprehensive ophthalmologic examinations. Results. The baseline prevalence of nonproliferative DR (NPDR) and proliferative DR (PDR) was 26.5% and 14.7%, respectively. Among 1303 patients with no DR and NPDR, 134 (10.3%) patients progressed to NPDR or PDR. The progression group had longer duration of diabetes, higher fasting plasma glucose, higher HbA1c, and a higher rate of ≥20% decline in eGFR during the follow-up period. After multivariate analysis, ≥20% decline in eGFR (odds ratio 2.553, 95% CI 1.219-5.348, p=0.013) was an independent risk factor for progression of DR in patients with NPDR. Conclusion. Declining renal function was independently associated with DR progression in patients with NPDR, suggesting that investigation of DR status should be recommended for patients with declining renal function.
format Article
id doaj-art-93fb2134b26a4adea79ec736c623830b
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-93fb2134b26a4adea79ec736c623830b2025-02-03T06:46:38ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/87841398784139Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 DiabetesAJin Cho0Hayne Cho Park1Young-Ki Lee2Young Joo Shin3So Hyun Bae4Hakyoung Kim5Department of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Internal Medicine, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Ophthalmology, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Ophthalmology, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaDepartment of Ophthalmology, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaBackground. At a university hospital in Korea, we conducted a retrospective study to determine the association of the progression of diabetic retinopathy (DR) with declining renal function in type 2 diabetes. Methods. We included a total of 1527 patients with type 2 diabetes who followed up in our diabetes clinic and underwent fundus photographic examinations from August 2006 to February 2014. DR was assessed by retinal ophthalmologists using comprehensive ophthalmologic examinations. Results. The baseline prevalence of nonproliferative DR (NPDR) and proliferative DR (PDR) was 26.5% and 14.7%, respectively. Among 1303 patients with no DR and NPDR, 134 (10.3%) patients progressed to NPDR or PDR. The progression group had longer duration of diabetes, higher fasting plasma glucose, higher HbA1c, and a higher rate of ≥20% decline in eGFR during the follow-up period. After multivariate analysis, ≥20% decline in eGFR (odds ratio 2.553, 95% CI 1.219-5.348, p=0.013) was an independent risk factor for progression of DR in patients with NPDR. Conclusion. Declining renal function was independently associated with DR progression in patients with NPDR, suggesting that investigation of DR status should be recommended for patients with declining renal function.http://dx.doi.org/10.1155/2020/8784139
spellingShingle AJin Cho
Hayne Cho Park
Young-Ki Lee
Young Joo Shin
So Hyun Bae
Hakyoung Kim
Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
Journal of Diabetes Research
title Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
title_full Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
title_fullStr Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
title_full_unstemmed Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
title_short Progression of Diabetic Retinopathy and Declining Renal Function in Patients with Type 2 Diabetes
title_sort progression of diabetic retinopathy and declining renal function in patients with type 2 diabetes
url http://dx.doi.org/10.1155/2020/8784139
work_keys_str_mv AT ajincho progressionofdiabeticretinopathyanddecliningrenalfunctioninpatientswithtype2diabetes
AT haynechopark progressionofdiabeticretinopathyanddecliningrenalfunctioninpatientswithtype2diabetes
AT youngkilee progressionofdiabeticretinopathyanddecliningrenalfunctioninpatientswithtype2diabetes
AT youngjooshin progressionofdiabeticretinopathyanddecliningrenalfunctioninpatientswithtype2diabetes
AT sohyunbae progressionofdiabeticretinopathyanddecliningrenalfunctioninpatientswithtype2diabetes
AT hakyoungkim progressionofdiabeticretinopathyanddecliningrenalfunctioninpatientswithtype2diabetes